As previously reported, lenabasum did not meet its primary efficacy endpoint in the study Lenabasum was well tolerated with no new safety findings Exploratory post-hoc analyses revealed unexpectedly low pulmonary exacerbation (PEx) rates in subjects from five eastern European countries (21% of total subjects) who received
Related News
Trevi Therapeutics Provides Clinical Trial Updates for Haduvio™
Restart ofPhase 2 Clinical Trial ofHaduviofor Chronic Cough in Patients with IPF Phase 2b/3PRISMTrial ofHaduviofor Severe Pruritus in Patients with...
Tyler Morning Telegraph
2020-10-21
Terns Pharmaceuticals to Present Clinical Data on Improved TERN-101 Tablet Formulation at the Paris NASH ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Oct 22, 2020-- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing best-in-class...
The Marshall News Messenger
2020-10-22
SEC Filing (8-K) - Current Report Filing
ovid-ex991_85.pptx.htm Angelman Syndrome & OV101 (gaboxadol) Seminar October 22, 2020 October 22, 2020 ©2020 OVID THERAPEUTICS INC. | ALL RIGHTS RESERVED Exhibit 99.1...
Public Technologies 2020-10-22AB Science announces positive top-line Phase 3 results for oral masitinib in severe asthma
AB Science announces positive top-line Phase 3 results for oral masitinib in severe asthma 20 Oct 2020 21:37 CEST Company Name AB SCIENCE ISN FR0010557264 Market Euronext...
Public Technologies 2020-10-20Alnylam Presents Positive Results from ILLUMINATE-B Phase 3 Study in Pediatric Patients with Primary Hyperoxaluria Type 1 at the American Society of Nephrology Kidney Week
Oct 22, 2020 Press Release for Alnylam Alnylam Presents Positive Results from ILLUMINATE-B Phase 3 Study in Pediatric Patients with Primary Hyperoxaluria Type 1 at the...
Public Technologies 2020-10-22Myovant Sciences Presents Additional Data on Relugolix Combination Therapy from Studies in Endometriosis and Uterine Fibroids
PDF Version Seven oral and poster presentationspresented at the American Society for Reproductive Medicine (ASRM) 2020 Virtual Congress Oral presentation on efficacy and...
Public Technologies 2020-10-21United Therapeutics Highlights Poster Presentations from the Recent CHEST 2020 Meeting
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 22, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced new clinical data on...
PR Newswire 2020-10-22